友情提示:以下期刊信息可能会有更新,仅供参考,请在投稿前自行登录期刊官网仔细核实。
期刊名
Expert Review of Vaccines
EXPERT REV VACCINES
ISSN / eISSN
1476-0584 / 1744-8395
目标和范围
Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review.
The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.
The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.
研究方向
免疫学
CiteScore
8.00
查看趋势图
CiteScore 学科排名
类别 | 分区 | 排名 |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery | Q1 | #34/156 |
Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q1 | #66/301 |
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q2 | #51/171 |
Pharmacology, Toxicology and Pharmaceutics - Immunology | Q2 | #71/217 |
Web of Science 核心合集
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
类别 (Journal Citation Reports 2023) | 分区 |
---|---|
IMMUNOLOGY - SCIE | Q2 |
H-index
75
出版国家或地区
ENGLAND
出版商
Taylor and Francis Ltd.
出版周期
Bimonthly
出版年份
2002
年文章数
125
Open Access
NO
通讯方式
EXPERT REVIEWS, UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now